Revance Therapeutics Inc (RVNC)
3.57
-0.09
(-2.46%)
USD |
NASDAQ |
Apr 24, 16:00
3.575
0.00 (0.00%)
After-Hours: 20:00
Revance Therapeutics Price: 3.57 for April 24, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 24, 2024 | 3.64 | 3.75 | 3.539 | 3.57 | 1.789M |
| Apr 23, 2024 | 3.64 | 3.81 | 3.62 | 3.66 | 1.589M |
| Apr 22, 2024 | 3.83 | 3.87 | 3.61 | 3.64 | 1.813M |
| Apr 19, 2024 | 3.80 | 3.87 | 3.71 | 3.78 | 1.648M |
| Apr 18, 2024 | 3.75 | 3.82 | 3.625 | 3.79 | 1.598M |
| Apr 17, 2024 | 3.87 | 3.90 | 3.74 | 3.76 | 1.740M |
| Apr 16, 2024 | 3.97 | 3.97 | 3.72 | 3.81 | 2.419M |
| Apr 15, 2024 | 4.08 | 4.19 | 3.96 | 3.97 | 2.122M |
| Apr 12, 2024 | 4.39 | 4.45 | 4.10 | 4.13 | 1.578M |
| Apr 11, 2024 | 4.45 | 4.53 | 4.21 | 4.44 | 1.882M |
| Apr 10, 2024 | 4.47 | 4.575 | 4.31 | 4.41 | 1.591M |
| Apr 09, 2024 | 4.49 | 4.94 | 4.47 | 4.69 | 1.775M |
| Apr 08, 2024 | 4.38 | 4.470 | 4.355 | 4.45 | 833494.0 |
| Apr 05, 2024 | 4.37 | 4.47 | 4.33 | 4.41 | 1.263M |
| Apr 04, 2024 | 4.65 | 4.70 | 4.36 | 4.41 | 1.057M |
| Apr 03, 2024 | 4.52 | 4.64 | 4.37 | 4.55 | 1.334M |
| Apr 02, 2024 | 4.61 | 4.63 | 4.45 | 4.51 | 1.722M |
| Apr 01, 2024 | 4.99 | 4.99 | 4.66 | 4.73 | 1.142M |
| Mar 28, 2024 | 5.00 | 5.03 | 4.855 | 4.92 | 1.245M |
| Mar 27, 2024 | 4.78 | 4.955 | 4.68 | 4.94 | 1.569M |
| Mar 26, 2024 | 4.70 | 4.90 | 4.63 | 4.70 | 1.109M |
| Mar 25, 2024 | 4.92 | 5.020 | 4.57 | 4.65 | 1.448M |
| Mar 22, 2024 | 5.16 | 5.16 | 4.86 | 4.87 | 969428.0 |
| Mar 21, 2024 | 5.10 | 5.42 | 5.095 | 5.19 | 1.463M |
| Mar 20, 2024 | 4.88 | 5.11 | 4.77 | 5.07 | 1.693M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.57
Minimum
Apr 24 2024
37.61
Maximum
May 09 2023
20.05
Average
20.30
Median
Nov 09 2022
Price Benchmarks
| AbbVie Inc | 167.80 |
| Alnylam Pharmaceuticals Inc | 143.80 |
| Ionis Pharmaceuticals Inc | 42.45 |
| Madrigal Pharmaceuticals Inc | 204.65 |
| Vertex Pharmaceuticals Inc | 400.76 |
Price Related Metrics
| PS Ratio | 1.290 |
| Earnings Yield | -106.4% |
| Market Cap | 372.04M |